5,401 results on '"semaglutide"'
Search Results
152. The Ameliorative Effects of GLP-1RA on Diabetic Cardiac Autonomatic Neuropathy
153. Semaglutide and Cognition in Healthy Volunteers (OxSENSE)
154. GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab (GLP-TEP)
155. Semaglutide Treatment for Hyperglycaemia After Renal Transplantation (Sema-RTx)
156. The Effects of Semaglutide on Body Composition and Performance in Military Personnel
157. Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity (STEP-HFpEF)
158. Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial
159. The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical Trial
160. Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes (RT1D)
161. Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
162. SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without Diabetes (SMART)
163. Semaglutide in Auto-HSCT (PROTECT)
164. RESHAPING TREATMENT PARADIGMS: Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry's pipeline remains flush with many late-stage therapies showing promising data and transformative potential
165. A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice
166. A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
167. A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
168. DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy (DOORS)
169. Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
170. Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure (FIT-HF)
171. Anti-obesity Pharmacotherapy and Inflammation
172. A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
173. Semaglutide for Post-Smoking Cessation Weight Management
174. The Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients With Type 2 Diabetes
175. A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight
176. Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)
177. A Study of Cardiovascular Events iN Diabetes Plus (ASCEND PLUS)
178. A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
179. A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE) (REALYSE)
180. A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes
181. Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
182. The Effect of Weekly Semaglutide Treatment on Energy Expenditure
183. Impact of Semaglutide on CD34+ EPC and Fat Derived MSC
184. Alleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide (SEMA SMA)
185. GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH (GLUCOSE-MGH)
186. Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment
187. The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.
188. A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together
189. Semaglutide in Nonalcoholic Fatty Liver Disease
190. Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease
191. Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
192. Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
193. Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
194. Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
195. COMMETS- Combination MCI Metabolic Syndrome
196. Effects of Semaglutide in HIV-Associated Lipohypertrophy
197. Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
198. Sit Less, Interact and Move More (SLIMM) 2 Study
199. GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery (GLUMINS)
200. A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.